Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study
Vera E. R. Asscher*, Vince B. C. Biemans, Marieke J. Pierik, Gerard Dijkstra, Mark Lowenberg, Sander van der Marel, Nanne K. H. de Boer, Alexander G. L. Bodelier, Jeroen M. Jansen, Rachel L. West, Jeoffrey J. L. Haans, Willemijn A. van Dop, Rinse K. Weersma, Frank Hoentjen, P. W. Jeroen Maljaars, Dutch Initiative Crohn and Colitis
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study'. Together they form a unique fingerprint.